A Review of the Latest Prevention and Treatment Strategies For COVID-19

Instructor: Dr. Afsaneh Motamed Khorasani
Product ID: 706536
Training Level: Intermediate
  • 27
  • August 2020
    Thursday
  • 08:00 AM PDT | 11:00 AM EDT
    Duration: 90 Min
This webinar is scientific in nature but simplified for people so that those without a strong scientific background can understand the content. It rules out the confusions circulating online about COVID-19 and the drugs and vaccine candidates for it.

Live Online Training
August 27, Thursday 08:00 AM PDT | 11:00 AM EDT | Duration: 90 Min

$349.00
One Dial-in One Attendee
$999.00
Purchase using Webinar All-Access Pass
(One user get unlimited access to all upcoming and recorded webinars (350+) for one year)

recorded version

$399.00
1x Person - Unlimited viewing for 6 Months
(For multiple locations contact Customer Care)
Recorded Link and Ref. material will be available in My CO Section 48 hrs after completion of Live training

Training CD / USB Drive

$499.00
One CD/USB is for usage in one location only.
(For multiple locations contact Customer Care)
CD/USB and Ref. material will be shipped within 15 business days after completion of Live training

Combo Offers

Live + Recorded Version

$529.00

Live + Training CD/USB

$629.00

Customer Care

Fax: +1-650-362-2367

Email: customercare@complianceonline.com

Read Frequently Asked Questions

Why Should You Attend:

There is a lot of confusion around what will happen to individuals, what this new enemy is that has suddenly appeared in our midst, interrupted/threatened our lives and what to do to stay safe.

The goal of this webinar it to provide clear information and provide an update to the latest prevention and treatment strategies for COVID-19.

The Coronaviruses (CoV) are positive sense RNA viruses possessing spike-like projections on the surface creating a crown-like appearance upon magnification with electron microscopy. They are a large family of viruses causing a wide range of illness from the common cold to more severe diseases, such as Middle East Respiratory Syndrome (MERS-CoV) and Severe Acute Respiratory Syndrome (SARS-CoV).

The novel coronavirus (2019-nCoV) or the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a man-made chimera that was engineered in 2015 in the University of North Carolina at Chapel Hill.

This engineered virus claimed its first victim in the Wuhan Institute of Virology, in Wuhan China in December 2019. On December 31st 2019, China notified the outbreak to the World Health Organization. The World Health Organization (WHO) on March 11, 2020, declared COVID-19 a pandemic, pointing to the over 118,000 cases of the coronavirus illness in over 110 countries and territories around the world and the sustained risk of further global spread.

We consider this epidemic a threat to the entire human life due to the lack of a sufficient preventive and treatment strategy to protect against it until now.

Learning Objectives:

  • Following the completion of this webinar, you will gain a basic to moderate knowledge of the prevention and treatment strategies available.
  • Countermeasures will be discussed at a high level and will be broken down into potential treatments that block the viral lifecycle (monoclonal antibodies, Camostat mesylate, chloroquine/hydroxychloroquine, lopinavir-ritonavir, remdesivir); potential anti-inflammatories (corticosteroids and baricitinib); immune boosters; and potential vaccines.

Areas Covered in the Webinar:

  • Epidemiology and pathogenesis
  • Transmission
  • Incubation period
  • Prevention
  • Risk factors
  • Therapeutic recommendations
  • Treatments:
    • Antiviral drugs
    • Broad spectrum antiviral drugs
    • Systemic corticosteroid treatment
    • Protease inhibitors
    • Anti-iflammatories
    • Antithrombotics/Anticoagolants
    • Monoclonal antibodies
    • Other proposed drugs for therapy
    • Vaccine Candidates
    • Natural Anti-Viral Agents
    • Herbal Extracts
    • Other Natural Sources

Who Will Benefit:

  • Anyone who has concerns about the COVID-19 pandemic and wants to understand more about the latest advances in prevention and treatment of COVID-19.
  • Professionals from any industry or company of any size.
Instructor Profile:
Afsaneh Motamed Khorasani

Dr. Afsaneh Motamed Khorasani
Vice President of Medical Affairs, Easy Global Training

Dr. Afsaneh Motamed Khorasani, PhD, is a Medical and scientific Affairs expert and a Senior Scientist with a strong background in biomedical science and clinical trial/research. She has a tenured and diverse range of experience in medical affairs, basic and industrial clinical research and development, clinical trials, Medical and regulatory writing and intellectual property. She is currently the Vice President of Medical Affairs at Easy Global Training, which is a US-based firm providing global regulatory, quality and medical affairs training backed by consulting. Before joining this company, Dr. Motamed Khorasani has served as an independent consultant, director of medical affairs, senior medical sciences liaison, senior scientist and senior medical analyst at Merck (MDS), Johnson & Johnson, United States Pharmacopeia Convention (USP), Amgen, Baxter International, Covidien (eV3), Radient Pharmaceuticals, AMDL Diagnostics, Microbix Biosystems, Neometrix Consulting, Mount Sinai Hospital, Princess Margaret Hospital, and Vancouver General Hospital.

She has more than 20 years of experience and many National and international certificates in GLP, GMP, ICH-GCP and global regulatory compliance for clinical trials and is a member in a number of professional associations, including: American Association of Cancer Research (AACR), American Medical Writers Association (AMWA), Regulatory Affairs Professional Society (RAPS), American Society of Quality (ASQ), Project Management Institute (PMI), and Intellectual Property Institute of Canada (IPIC). Dr. Motamed Khorasani's research has focused on high throughput approaches in the context of cancer informatics with a particular interest in the use of comparative analysis for the mining of integrated oncology datasets that include protein-protein interaction and gene expression profiling. She has published and presented more than 50 papers, abstracts and articles in highly regarded scientific journals and high profile conferences and scientific meetings.

Follow us :
Preparing for FDA's New Import/Export Trauma in 2020

Refund Policy

Registrants may cancel up to two working days prior to the course start date and will receive a letter of credit to be used towards a future course up to one year from date of issuance. ComplianceOnline would process/provide refund if the Live Webinar has been cancelled. The attendee could choose between the recorded version of the webinar or refund for any cancelled webinar. Refunds will not be given to participants who do not show up for the webinar. On-Demand Recordings can be requested in exchange.

Webinar may be cancelled due to lack of enrolment or unavoidable factors. Registrants will be notified 24hours in advance if a cancellation occurs. Substitutions can happen any time.

If you have any concern about the content of the webinar and not satisfied please contact us at below email or by call mentioning your feedback for resolution of the matter.

We respect feedback/opinions of our customers which enables us to improve our products and services. To contact us please email customercare@complianceonline.com call +1-888-717-2436 (Toll Free).

Product Reviews

This product hasn't received any reviews yet. Be the first to review this product! Write review

Best Sellers
You Recently Viewed
    Loading